PHILADELPHIA TRUST CO - HUMACYTE INC ownership

HUMACYTE INC's ticker is and the CUSIP is 44486Q103. A total of 72 filers reported holding HUMACYTE INC in Q3 2022. The put-call ratio across all filers is 0.96 and the average weighting 0.0%.

Quarter-by-quarter ownership
PHILADELPHIA TRUST CO ownership history of HUMACYTE INC
ValueSharesWeighting
Q3 2023$290.0%10,0000.0%0.00%0.0%
Q2 2023$29
-6.5%
10,0000.0%0.00%0.0%
Q1 2023$31
+47.6%
10,0000.0%0.00%
+50.0%
Q4 2022$21
-99.9%
10,0000.0%0.00%
-50.0%
Q3 2022$33,000
+3.1%
10,0000.0%0.00%
+33.3%
Q2 2022$32,000
-54.9%
10,0000.0%0.00%
-50.0%
Q1 2022$71,000
-2.7%
10,0000.0%0.01%
+20.0%
Q4 2021$73,000
-58.0%
10,000
-33.3%
0.01%
-61.5%
Q3 2021$174,00015,0000.01%
Other shareholders
HUMACYTE INC shareholders Q3 2022
NameSharesValueWeighting ↓
Imprint Wealth LLC 257,119$938,4120.62%
Endowment Wealth Management, Inc. 96,618$298,5500.30%
Prescott General Partners LLC 568,246$1,755,8800.14%
HAMILTON LANE ADVISORS LLC 52,693$1630.06%
United Asset Strategies, Inc. 58,960$182,1860.02%
Kovack Advisors, Inc. 35,000$108,1500.02%
Shay Capital LLC 19,987$61,7600.01%
Y-Intercept (Hong Kong) Ltd 14,565$45,0060.01%
Mendota Financial Group, LLC 500$3,5300.00%
PHILADELPHIA TRUST CO 10,000$310.00%
View complete list of HUMACYTE INC shareholders